JP2002519423A5 - - Google Patents

Download PDF

Info

Publication number
JP2002519423A5
JP2002519423A5 JP2000558098A JP2000558098A JP2002519423A5 JP 2002519423 A5 JP2002519423 A5 JP 2002519423A5 JP 2000558098 A JP2000558098 A JP 2000558098A JP 2000558098 A JP2000558098 A JP 2000558098A JP 2002519423 A5 JP2002519423 A5 JP 2002519423A5
Authority
JP
Japan
Prior art keywords
alkoxy
hydroxyl
compound
formula
carboxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000558098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002519423A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/004451 external-priority patent/WO2000001695A1/en
Publication of JP2002519423A publication Critical patent/JP2002519423A/ja
Publication of JP2002519423A5 publication Critical patent/JP2002519423A5/ja
Withdrawn legal-status Critical Current

Links

JP2000558098A 1998-07-06 1999-06-26 Ped阻害作用を有する新規ベンゾオキサゾール Withdrawn JP2002519423A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98112469.6 1998-07-06
EP98112469 1998-07-06
PCT/EP1999/004451 WO2000001695A1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Publications (2)

Publication Number Publication Date
JP2002519423A JP2002519423A (ja) 2002-07-02
JP2002519423A5 true JP2002519423A5 (enExample) 2006-08-31

Family

ID=8232222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000558098A Withdrawn JP2002519423A (ja) 1998-07-06 1999-06-26 Ped阻害作用を有する新規ベンゾオキサゾール

Country Status (14)

Country Link
US (1) US6376485B1 (enExample)
EP (1) EP1095040B1 (enExample)
JP (1) JP2002519423A (enExample)
AT (1) ATE263166T1 (enExample)
AU (1) AU761647B2 (enExample)
CA (1) CA2336894A1 (enExample)
DE (1) DE69916066T2 (enExample)
DK (1) DK1095040T3 (enExample)
ES (1) ES2219031T3 (enExample)
IL (1) IL140468A0 (enExample)
PT (1) PT1095040E (enExample)
SI (1) SI1095040T1 (enExample)
WO (1) WO2000001695A1 (enExample)
ZA (1) ZA200100088B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2225215A1 (en) * 2007-11-21 2010-09-08 Decode Genetics EHF Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405633A (en) * 1982-03-01 1983-09-20 Usv Pharmaceutical Corporation Method of treatment of asthma
US4490373A (en) * 1983-05-20 1984-12-25 Usv Pharmaceutical Corporation Method of treating asthma
KR100237962B1 (ko) * 1994-10-12 2000-02-01 그린 마틴 신규한 벤즈옥사졸
DE59610031D1 (de) * 1995-05-18 2003-02-06 Altana Pharma Ag Cyclohexyldihydrobenzofurane
WO1996036624A1 (en) * 1995-05-19 1996-11-21 Kyowa Hakko Kogyo Co., Ltd. Oxygen-containing heterocyclic compounds

Similar Documents

Publication Publication Date Title
JP2002519423A5 (enExample)
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2002508361A5 (enExample)
DK1341542T3 (da) Indanylderivater til behandling af luftvejssygdomme
JP2005539088A5 (enExample)
JP2003528918A5 (enExample)
RU2005108133A (ru) Дипептиднитрильные ингибиторы катепсина к
JP2002513793A5 (enExample)
JP2003531118A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
ATE235471T1 (de) Neue benzylpyrimidine
JP2005511547A5 (enExample)
JP2003503449A5 (enExample)
JP2002526539A5 (enExample)
JP2010522710A5 (enExample)
JP2015508097A5 (enExample)
JP2008512408A5 (enExample)
RU2004101229A (ru) Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения
JP2002520286A5 (enExample)
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
CA2433039A1 (en) Agent for therapeutic and prophylactic treatment of neuropathic pain
JP2002526530A5 (enExample)
JP2002539089A5 (enExample)
RU2010147826A (ru) Ацилоксиалкилкарбаматные пролекарства, способы синтеза и применение
RU2007125130A (ru) Применение атазанавира для улучшения фармакокинетики лекарственных средств, метаболизируемых ugt1a1